glp-1 obesity drug news today september 15 2025 Weight-loss makers announce pricing agreement with Trump The push for Medicare to

O., da Silva Monteiro, C

By 2030, the global prevalence of obesity is expected to reach one billion

Liver: NAD+ therapy may help to improve liver function

This action may contribute to improved overall health and a reduced risk of inflammatory-related conditions

"For consumers, the bottom line is simple: If a product claims to work 'just like a GLP-1 drug,' promises dramatic weight loss, or minimizes risk with slogans like 'all the benefits without the discomfort,' that should be a red flag," Ventura says

RNA sequencing was conducted to define the transcriptional profiles of peripheral blood mononuclear cells after L-Cn stimulation